Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Intracranial atherosclerotic disease is the progressive narrowing of the cerebral arteries within the skull (intracranial). The arteries that supply oxygen-enriched blood to the brain are the carotid arteries and the vertebral arteries. The circle of Willis is the area at the base of the brain that joins these arteries. Stenosis (narrowing) of the artery walls in intracranial atherosclerotic disease (ICAD) develops similarly to atherosclerosis of the heart: from the buildup of plaque, also known as an atherosclerotic lesion. The product in this report is Stent and PTA balloon for Treatment of ICAD.

According to our (Global Info Research) latest study, the global ICAD (Intracranial Atherosclerotic Disease) Pathology market size was valued at US$ 196 million in 2023 and is forecast to a readjusted size of USD 347 million by 2030 with a CAGR of 8.6% during review period.

Global ICAD (Intracranial Atherosclerotic Disease) Pathology key players include Stryker, Balt, TERUMO, MicroPort, Acandis, etc. Global top five manufacturers hold a share about 90%. Asia-Pacific is the largest market, with a share about 45%, followed by North America, with a share about 25 percent. In terms of product, Stent is the largest segment, with a share about 80%. And in terms of application, the largest application is Hospital, followed by Clinic, etc.

This report is a detailed and comprehensive analysis for global ICAD (Intracranial Atherosclerotic Disease) Pathology market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:

Global ICAD (Intracranial Atherosclerotic Disease) Pathology market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (USD/Unit), 2019-2030

Global ICAD (Intracranial Atherosclerotic Disease) Pathology market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (USD/Unit), 2019-2030

Global ICAD (Intracranial Atherosclerotic Disease) Pathology market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (USD/Unit), 2019-2030

Global ICAD (Intracranial Atherosclerotic Disease) Pathology market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (USD/Unit), 2019-2024

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for ICAD (Intracranial Atherosclerotic Disease) Pathology

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global ICAD (Intracranial Atherosclerotic Disease) Pathology market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Stryker, Balt, TERUMO, MicroPort, Acandis, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

ICAD (Intracranial Atherosclerotic Disease) Pathology market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Stent
PTA Balloon

Market segment by Application
Hospital
Clinic
Other

Major players covered
Stryker
Balt
TERUMO
MicroPort
Acandis

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe ICAD (Intracranial Atherosclerotic Disease) Pathology product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of ICAD (Intracranial Atherosclerotic Disease) Pathology, with price, sales quantity, revenue, and global market share of ICAD (Intracranial Atherosclerotic Disease) Pathology from 2019 to 2024.

Chapter 3, the ICAD (Intracranial Atherosclerotic Disease) Pathology competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the ICAD (Intracranial Atherosclerotic Disease) Pathology breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.

Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and ICAD (Intracranial Atherosclerotic Disease) Pathology market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of ICAD (Intracranial Atherosclerotic Disease) Pathology.

Chapter 14 and 15, to describe ICAD (Intracranial Atherosclerotic Disease) Pathology sales channel, distributors, customers, research findings and conclusion.